Hashimoto’s Encephalopathy with Positive 14-3-3 Protein in the Cerebrospinal Fluid and Atypical Course Mimicking Creutzfeldt-Jakob DiseaseHashimoto’s Encephalopathy with Positive 14-3-3 Protein in the Cerebrospinal Fluid and Atypical Course Mimicking Creutzfeldt-Jakob Disease
- Other Titles
- Hashimoto’s Encephalopathy with Positive 14-3-3 Protein in the Cerebrospinal Fluid and Atypical Course Mimicking Creutzfeldt-Jakob Disease
- Authors
- Jee-Eun Yoon; 김지선; Kyung Bok Lee; 노학재; 안무영
- Issue Date
- 2015
- Publisher
- 대한치매학회
- Keywords
- Creutzfeldt-Jakob disease; Hashimoto’s encephalopathy; 14-3-3 protein.
- Citation
- Dementia and Neurocognitive Disorders(대한치매학회지), v.14, no.4, pp 172 - 175
- Pages
- 4
- Journal Title
- Dementia and Neurocognitive Disorders(대한치매학회지)
- Volume
- 14
- Number
- 4
- Start Page
- 172
- End Page
- 175
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11117
- DOI
- 10.12779/dnd.2015.14.4.172
- ISSN
- 1738-1495
2384-0757
- Abstract
- Background Creutzfeldt-Jakob disease (CJD) shares common clinical features with Hashimoto’s encephalopathy (HE). The 14-3-3 proteinis a relatively sensitive and specific marker of CJD but is not commonly detected in HE. We report the case of a patient with HE with unusualfeatures including positive 14-3-3 protein in the cerebrospinal fluid (CSF) and an atypical course mimicking that of CJD.
Case Report A 64-year-old male was admitted due to acute-onset cognitive dysfunction. HE was suspected based on increased titers ofanti-thyroid microsomal antibody and an excellent response to steroid. However, 14-3-3 protein was detected in the CSF and a recurrent attackwith progressive cognitive decline, pyramidal symptoms and myoclonus mimicking CJD occurred. Cognitive dysfunction showed progressiveworsening and the response to steroid treatment was decreased.
Conclusions 14-3-3 protein could be considered a general marker of neuronal destruction and not specific to CJD. The clinical manifestationsof HE are variable and its diagnosis is difficult due to the lack of a specific phenotype and reliable diagnostic criteria. We recommendthat patients with clinical features of CJD and antithyroid antibodies should be considered for empirical steroid treatment for HE, despite apositive result for 14-3-3 protein.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Neurology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11117)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.